AngioDynamics Inc (STU:UG2)
€ 5.9 0.05 (0.85%) Market Cap: 229.90 Mil Enterprise Value: 181.36 Mil PE Ratio: 0 PB Ratio: 1.16 GF Score: 57/100

AngioDynamics Inc at Barclays Global Healthcare Conference Transcript

Mar 16, 2022 / 01:00PM GMT
Release Date Price: €20.4
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

Good morning, everybody. My name is Luke Sergott. I cover life science tools and diagnostics here at Barclays, and this is my foray into the biotech space -- or I'm sorry, med device space. I have Stephen Trowbridge with me and Jim Clemmer of AngioDynamics who are going to give a presentation.

James C. Clemmer
AngioDynamics, Inc. - CEO, President & Director

Good morning, Luke. Thank you Thanks Barclays for having the courage to plan an in-person meeting. This is a challenging environment. So thanks for the invitation. Let me remind you, sophisticated investors, you understand what you hear this morning, our ideas, projections, plans, strategies. And I always consider the forward-looking statements that you're here to make sure you make good decisions as you invest. .

So let's talk about AngioDynamics for a little bit. We're a company in transformation. And what we're doing is transforming from -- we've always been a diversified medical device company. Well, today, we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot